Johnson & Johnson (JNJ)

152,21 +1,08 (+0,71%) Ab 01:17PM EDT. Markt geöffnet.

Johnson & Johnson

One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States
732 524 0400
https://www.jnj.com

Sektor(en): Healthcare
Branche: Drug Manufacturers—General
Vollzeitmitarbeiter: 152.700

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Joaquin Duato	CEO & Chairman	4,84M	8,65M	1963
Mr. Joseph J. Wolk CPA	Exec. VP & CFO	2,26M	1,35M	1967
Ms. Ashley A. McEvoy	Exec. VP & Worldwide Chairman of MedTech	1,92M	7,55M	1971
Ms. Jennifer L. Taubert	Exec. VP & Worldwide Chairman of Pharmaceuticals	2,16M	8,02M	1964
Mr. Thibaut Mongon	Exec. VP & Worldwide Chairman of Consumer Health	1,91M	4,83M	1971
Mr. Robert J. Decker Jr.	Controller & Chief Accounting Officer	N/A	N/A	1972
Mr. James Swanson	Exec. VP & Chief Information Officer	N/A	N/A	1966
Ms. Jessica Moore	VP of Investor Relations	N/A	N/A	N/A
Mr. Dirk Brinckman	Chief Compliance Officer	N/A	N/A	N/A
Ms. Elizabeth Forminard	Exec. VP & Gen. Counsel	N/A	N/A	1971

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Corporate Governance

Johnson & Johnsons ISS Governance QualityScore, Stand 1. März 2023, lautet 6. Die grundlegenden Scores sind Audit: 10, Vorstand: 6, Shareholderrechte: 2, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.